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I.

Introduction.

Alcohol use disorder (AUD) negatively impacts individuals, communities and has a
significant economic effect. Binge drinking is the third leading cause of preventable deaths in the
United States (Sacks et al., 2015; Witkiewitz et al., 2019). Binge drinking is characterized as
reaching a blood alcohol level (BAL) of >80mg% within a 2-hour time period (National Institute
on Alcohol Abuse and Alcoholism, 2004). The COVID-19 pandemic has brought further
challenges to those with AUD, as a change in alcohol availability and the impact of isolation
have caused an increase in alcohol use. In contrast, countries that enacted alcohol restrictions
have shown higher rates of fatal alcohol withdrawal (Nadkarni et al., 2020).
Alcoholism causes a disruption in circadian rhythms that continues into sobriety and
increases the risk for relapse (Brower, 2001; Fonzi et al., 1994; Landolt et al., 1996; Sano et al.,
1993). Circadian rhythms operate on a 24-hour time period to regulate the sleep/wake cycle,
hormone regulation, physiology, and behavior. The cyclical rhythm has known peaks and troughs
that fluctuate and are affected by light input. The ventral tegmental area (VTA) plays an
important role in reward, motivation, addiction, and molecular clock function. The Ozburn lab
found abstinence from ethanol causes a reduced expression of the Circadian Locomotor Output
Cycles Kaput (Clock) gene in the VTA of wild-type (WT) mice (Ozburn et al., 2013).
To study the effects of apremilast on binge-like drinking, high drinking in the dark (HDID)
mice are used as a model organism. The HDID mice were bred to binge drink and show
withdrawal following a single drinking session. These mice were chosen as they are genetically
identical, allowing for a high-risk model for binge-like ethanol drinking (Crabbe et al., 2017,
2009).

Harm reduction research is necessary to alleviate the effects of chronic binge drinking.
Improving circadian rhythms, which are affected during and following drinking, may lessen the
harmful effects of alcohol. Individuals with disturbed circadian rhythms are more apt to relapse.
Remediating the effects of binge drinking on the circadian rhythm suggests the potential to
decrease alcohol intake while increasing Clock function. In addition, pharmacologically targeting
the phosphodiesterase-4 (PDE4) inhibitor may increase Clock gene expression in the VTA and
decrease alcohol intake.
II.

Research Question.

The research question addresses if PDE4 inhibitor, apremilast, can reduce binge-like drinking
in HDID mice. Furthermore, the experiment investigates if apremilast increases levels of
circadian gene expression in the VTA of HDID mice with a history of chronic binge-like
drinking. The expected results of apremilast treatment will increase Clock gene expression in the
VTA and decrease binge-like drinking.
III.

Literature Review.

Ethanol consumption affects Clock gene expression in animal models, as shown by the
Ozburn lab. Research suggests mice with a mutation in the Clock gene (Clock∆19) have an
increased preference for stimulant rewards and sucrose. Reducing Clock function in the VTA of
WT mice increased the amount of ethanol consumed, similar to the Clock∆19 mice. The Ozburn
lab found Clock expression in the VTA plays an important role as a negative regulator of ethanol
intake (Ozburn et al., 2013).
Another medication that has been researched to rescue the harmful effects of chronic binge
drinking is rolipram. Rolipram and apremilast are shown to increase cyclic adenosine
monophosphate (cAMP); both these medications are PDE4 inhibitors. PDE4 is an enzyme

responsible for the hydrolysis of cAMP. Compounds that increase cAMP can increase circadian
gene expression (Clarke et al., 2017; Spanagel et al., 2005a, Spanagel et al., 2005b). Rolipram
was shown to reduce ethanol intake in mice (Hu et al., 2011). Apremilast is FDA approved for
psoriasis and psoriatic arthritis, and in preclinical trials is shown to reduce ethanal intake
(Blednov et al., 2018).
IV.

Methodology.

This experiment uses adult male and female inbred HDID as a simple chronic binge-like
drinking genetic animal model. This experiment uses an 8-week Drinking in the Dark (DID)
paradigm. Two-time points were accessed to account for the circadian peaks and troughs of
nocturnal drinking patterns. Mice were given access to ethanol 20% at 3 hours into their active
dark cycle [Zeitgeber time (ZT 15)]. At ZT 15 the mice are active with the lights turned off.
Timepoint ZT 3 is a trough in gene expression where circadian genes are least expressed.
Whereas ZT 15, is a peak in expression and circadian genes show a higher rate of expression
while the mice are active.
For the DID, the mice were given access to water or ethanol 20% at the timepoint ZT 15. The
first days of DID, days 1-3, lasted 2 hours, while the final DID session on day 4 lasted 4 hours.
The mice underwent DID for 6 weeks to develop a high binge-like drinking average baseline. For
weeks 7 and 8, the mice received intraperitoneal injections (IP) of saline or 40 mg/kg apremilast
an hour prior to DID. Euthanization of mice was performed one day after the final DID session at
either ZT 3 or ZT 15 to account for the peaks and troughs.
Circadian gene expression is measured using qualitative real-time polymerase chain reaction
(qPCR). The VTA mRNA is isolated and quantified using a method described by (Ozburn et al.,
2017). The levels of Clock expression is measured by synthesis of cDNA using the BioRad iScript

Kit. The levels of circadian genes (Clock, Npas, Per1, or Per 2) will be measured in comparison
to 18s, a housekeeping gene that remains unchanged following ethanol exposure or change in time.
Data analysis will use a 3-way ANOVA to compare across (sex x treatment x ZT). If no sex
differences are found, the data will be collapsed across sex for analyses and compared across
treatment and time tissue was collected.
V.

Discussion.

This experiment is ongoing, and the results expected from this correlational study include
an increase in circadian gene expression in the VTA ameliorating the effects of chronic bingelike drinking on the molecular clock. Treatment is expected to decrease the amount of ethanol
voluntarily consumed while normalizing circadian gene expression. This study will examine the
mechanism of action for the use of apremilast treatment to understand the effects on binge-like
drinking. A limitation of this preliminary study is the absence of a water control group to test the
effects of apremilast on fluid intake. This is an important first step in determining the effects of
treatment, as early data shows apremilast to be useful in nontreatment-seeking AUD individuals
(Walker & Lawrence, 2018). Regulation of the molecular clock is important as chronic binge
drinking disrupts the expression of genes associated with neuronal signaling, cellular
metabolism, immune signaling, and hormone regulation. Going forward, this pilot project will
determine if more control groups and time points will be studied to better understand the effects
of apremilast on circadian rhythm within the VTA and decrease ethanol binge-like drinking.
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